Home-based interventions for black patients with uncontrolled hypertension: a cluster randomized controlled trial

J Comp Eff Res. 2016 Mar;5(2):155-68. doi: 10.2217/cer.15.60. Epub 2016 Mar 7.

Abstract

Aim: Assess the comparative effectiveness of two blood pressure (BP) control interventions for black patients with uncontrolled hypertension.

Patients & methods: A total of 845 patients were enrolled in a three-arm cluster randomized trial. On admission of an eligible patient, field nurses were randomized to usual care, a basic or augmented intervention.

Results: Across study arms there were no significant 12 months differences in BP control rates (primary outcome) (25% usual care, 26% basic intervention, 22% augmented intervention); systolic BP (143.8 millimeters of mercury [mmHg], 146.9 mmHG, 143.9 mmHG, respectively); medication intensification (47, 43, 54%, respectively); or self-management score (18.7, 18.7, 17.9, respectively). Adjusted systolic BP dropped more than 10 mmHg from baseline to 12 months (155.5-145.4 mmHg) among all study participants.

Conclusion: Neither the augmented nor basic intervention was more effective than usual care in improving BP control, systolic BP, medication intensification or patient self-management. Usual home care yielded substantial improvements, creating a high comparative effectiveness threshold.

Clinical trial registration: NCT00139490.

Keywords: blood pressure; comparative effectiveness; home care; hypertension; nurse-led interventions.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Black or African American / statistics & numerical data*
  • Cluster Analysis
  • Comparative Effectiveness Research / statistics & numerical data*
  • Female
  • Follow-Up Studies
  • Home Care Services / statistics & numerical data*
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • New York
  • Prospective Studies
  • Self Care / statistics & numerical data*

Substances

  • Antihypertensive Agents

Associated data

  • ClinicalTrials.gov/NCT00139490